Workflow
cardiovascular issues
icon
Search documents
Jim Cramer Says He “Should Have Been Recommending Regeneron”
Yahoo Finance· 2025-11-23 19:51
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the stocks Jim Cramer answered questions about. Answering a caller’s query about the stock, Cramer stated: “I should have been recommending Regeneron. That Len Schleifer pulled the rabbit out of a hat. It’s coming right back right now. By the way, I’ll give you a twofer, so is Amgen.” Stock market data showing an upward trajectory. Photo by Burak The Weekender on Pexels Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) sells medicines for eye conditi ...